{"disease":{"id":"variable-depending-on-investigator-selection-typically-used-as-a-control-arm-in-phase-3-oncology-trials","name":"variable depending on investigator selection typically used as a control arm in phase 3 oncology trials"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}